Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare
Zevra Therapeutics, Inc. Shareholder Equity 2013–2025
Zevra Therapeutics, Inc. annual/quarterly shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Zevra Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were 154.7M, a 289.90% increase year-over-year.
- Zevra Therapeutics, Inc. shareholder equity for 2025 were 154.7M, a 289.90% increase from 2024.
- Zevra Therapeutics, Inc. shareholder equity for 2024 were 39.7M, a 35.88% decrease from 2023.
- Zevra Therapeutics, Inc. shareholder equity for 2023 were 61.9M, a 17.65% decrease from 2022.
- Zevra Therapeutics, Inc. shareholder equity for 2022 were 75.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Zevra Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $155 |
| 2024 | $40 |
| 2023 | $62 |
| 2022 | $75 |
| 2021 | $102 |
| 2020 | $-66 |
| 2019 | $-74 |
| 2018 | $-67 |
| 2015 | $-10 |
| 2014 | $-49 |
| Zevra Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $155 |
| 2024-12-31 | $40 |
| 2023-12-31 | $62 |
| 2022-12-31 | $75 |
| 2021-12-31 | $102 |
| 2020-12-31 | $-66 |
| 2019-12-31 | $-74 |
| 2018-12-31 | $-67 |
| 2015-12-31 | $-10 |
| 2014-12-31 | $-49 |
Zevra Therapeutics, Inc. Shareholder Equity — FAQ
Zevra Therapeutics, Inc. (ZVRA) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZVRA's shareholder equity history?
The chart and table above show Zevra Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.